(Total Views: 645)
Posted On: 09/23/2020 11:56:29 AM
Post# of 155057
According to a poster on YMB, it seems their trial data will not be available until November/December.
It is a little confusing because it's a small trial to begin with. On clinicaltrials.gov, it says 144 patients and it is a Phase 2.
In the 21 patient study there were 2 SAEs (hypotension) and 4 cases of diarrhea, which I guess would be an AE, but not an SAE. So it doesn't even have the impeccable safety profile that leronlimab has.
I don't know if they are wasting their time or merely trying to pump the sp.
It is a little confusing because it's a small trial to begin with. On clinicaltrials.gov, it says 144 patients and it is a Phase 2.
In the 21 patient study there were 2 SAEs (hypotension) and 4 cases of diarrhea, which I guess would be an AE, but not an SAE. So it doesn't even have the impeccable safety profile that leronlimab has.
I don't know if they are wasting their time or merely trying to pump the sp.
(0)
(0)
